Transmembrane protein expressed in prostate cancer
US6943235B1 · kind B1 · utility
21Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2000 |
| Grant date | Sep 13, 2005 |
| Priority date | — |
| Expiry date | Apr 12, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24PC12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.